Fundraising FoxInvivo Therapeutics Holdings
Cambridge, US · Nevada corporation
Find your way into Invivo Therapeutics Holdings
Sign up to see every warm intro you have to Invivo Therapeutics Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Invivo Therapeutics Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RC
Richard ChristopherExecutive
RT
Richard ToselliExecutive
RR
Richard RobertsNamed on SEC filing
RR
Robert RosenthalNamed on SEC filing
CM
Christina MorrisonNamed on SEC filing
DM
Daniel MarshakNamed on SEC filing
CA
C. Ann MerrifieldNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$9.3M disclosed across 2 rounds · 2020–2022
▶$6.2MraisedOct 2022 · 1 investors · BiotechnologyRule 506(b)
▶$6.2MraisedOct 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert RosenthalDirector
- Richard RobertsDirector
- C. Ann MerrifieldDirector
- Daniel MarshakDirector
- Christina MorrisonDirector
- Heather HamelExecutive Officer
- Richard ChristopherExecutive Officer
- Richard ToselliExecutive Officer, Director
- Offering amount
- $6.2M
- Amount sold
- $6.2M
- Sales commissions
- $531.3K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Oct 2022
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$3MraisedApr 2020 · 8 investors · BiotechnologyRule 506(b)
▶$3MraisedApr 2020 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard RobertsDirector
- Robert RosenthalDirector
- Richard ChristopherExecutive Officer
- Christina MorrisonDirector
- Richard ToselliExecutive Officer, Director
- Daniel MarshakDirector
- C. Ann MerrifieldDirector
- Offering amount
- $3M
- Amount sold
- $3M
- Sales commissions
- $255.2K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Apr 2020
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Invivo Therapeutics Holdings raised?
- Invivo Therapeutics Holdings has disclosed $9.3M raised across 2 rounds.
- Where is Invivo Therapeutics Holdings headquartered?
- Invivo Therapeutics Holdings is headquartered in Cambridge, US.